Summary
Highlights
CRISPR-Cas9 is a revolutionary genome editing technology that offers precise and site-specific gene editing capabilities, providing unprecedented control over manipulating genetic information in living organisms. The video begins by setting the historical context.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) were first reported in 1987 in E. coli. These short, repeated DNA sequences found in prokaryotes were later discovered in the mid-2000s to be a key component of their adaptive immunity, protecting them from viral DNA and other mobile genetic elements. Bacteria incorporate viral DNA segments as 'spacers' between palindromic repeats, creating a 'memory' of past infections.
When a bacterium is infected by a bacteriophage, a piece of viral DNA is incorporated into the bacterial genome as a spacer, forming a CRISPR array. This array is transcribed into pre-crRNA, which then complexes with Cas9 protein and tracrRNA. Ribonuclease III cleaves this complex into individual effector complexes. If this complex encounters complementary viral DNA with a protospacer adjacent motif (PAM), Cas9 snips both DNA strands, neutralizing the virus.
In 2012, Jennifer Doudna and Emmanuelle Charpentier proposed adapting the bacterial CRISPR-Cas9 system for genome editing in humans and other animal species, earning them the Nobel Prize in Chemistry in 2020. A key breakthrough was combining crRNA and tracrRNA into a single synthetic 'single guide RNA' (sgRNA), which, when complexed with Cas9, can precisely cleave DNA at any desired target sequence.
After Cas9 cleaves DNA, the cell's natural repair mechanisms are activated. There are two primary routes: Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR). NHEJ repairs breaks by directly ligating ends, often leading to insertions or deletions (indels). HDR, more complex, uses a homologous DNA template to guide repair and incorporate new DNA fragments, minimizing errors and maintaining sequence uniformity.
CRISPR's potential applications are vast. It's used in cancer immunotherapy to genetically modify T cells to fight cancer, in therapeutic management of AIDS to target HIV proviruses, and in developing diagnostic assays for infections like SARS-CoV-2. Beyond human health, CRISPR can improve agricultural yields, plant resistance, and introduce specific traits in plants. While ethical concerns exist, CRISPR holds immense promise for curing diseases and preventing genetic disorders.